| This article has been cited by |
| 1 | Stability of extemporaneously prepared rosuvastatin oral suspension | |
| Abdel Naser Zaid,Rania Shtayah,Ayman Qadumi,Mashour Ghanem,Rawan Qedan,Marah Daibes,Somud Abu Awwad,Nidal Jaradat,Naim Kittana |
| American Journal of Health-System Pharmacy.2017;74(19)1579 |
| [DOI] |
|
| 2 | A comparison of the effectiveness of rosuvastatin, atorvastatin and simvastatin in achieving target lipid levels (according to the PROFILE-I registry) | |
| Oleg V Gaisenok |
| Journal of Clinical Medicine of Kazakhstan.2017;4(46)20 |
| [DOI] |
|
| 3 | Frequency of rhabdomyolysis in patients treated with statins in hamad general hospital, Qatar | |
| AbdelmonemBadawi Yousif,EbtihalAbdelmoneim Hassan,MutieUllah Ahmed,MonaS Lashin,NeathuMaria Kunjumon,TheebOsama Sulaiman,Maram Saliba,AmerA Shier,MonaM Babikir,WalaaA Saeed,AhmedAli Farghaly,FahmiYousef Khan |
| Libyan Journal of Medical Sciences.2021;5(2)75 |
| [DOI] |
|
| 4 | Effects of isolated or combined exposure to sibutramine and rosuvastatin on reproductive parameters of adult male rats | |
| Patrícia Villela Silva,Cibele dos Santos Borges,Josiane de Lima Rosa,Tainá Louise Pacheco,Thamiris Moreira Figueiredo,Gabriel Adan Araújo Leite,Marina Trevizan Guerra,Janete Aparecida Anselmo-Franci,Gary Robert Klinefelter,Wilma De Grava Kempinas |
| Journal of Applied Toxicology.2020;40(7)947 |
| [DOI] |
|
| 5 | Computation-Aided Engineering of Cytochrome P450 for the Production of Pravastatin | |
| Mark A. Ashworth,Elvira Bombino,René M. de Jong,Hein J. Wijma,Dick B. Janssen,Kirsty J. McLean,Andrew W. Munro |
| ACS Catalysis.2022;12(24)15028 |
| [DOI] |
|
| 6 | Efficiency of atorvastatin on in-hospital mortality of patients with acute aortic dissection (AAD): study protocol for a randomized, open-label, superiority clinical trial | |
| Yequn Chen,Nianling Xiong,Xin Wang,Shiwan Wu,Liangli Hong,Xiru Huang,Chang Chen,Weiping Li,Bin Wang,Shu Ye,Xuerui Tan |
| Trials.2021;22(1)15028 |
| [DOI] |
|
| 7 | Efficacy and adverse reaction to different doses of atorvastatin in the treatment of type II diabetes mellitus | |
| Hua Jiang,Hong Zheng |
| Bioscience Reports.2019;39(7)15028 |
| [DOI] |
|
| 8 | Efficacy and adverse reaction to different doses of atorvastatin in the treatment of type II diabetes mellitus | |
| Tran-Thi Nhu-Trang,Hoang-Nguyen Nguyen,Thi-Xong Thach,Hoang-Nguyen Nguyen,Cong-Hau Nguyen,Minh Huy Do |
| Bioscience Reports.2022;2656(7)060002 |
| [DOI] |
|
| 9 | Efficacy and adverse reaction to different doses of atorvastatin in the treatment of type II diabetes mellitus | |
| Abdel B. Halim |
| Bioscience Reports.2019;2656(7)215 |
| [DOI] |
|
